IGF‐1 Optimizes Mitochondrial Function Through AMP‐Activated Protein Kinase in Adult Sensory Neurons
Authors: Aghanoori Mohamad‐Reza , Sabbir Mohammad Golam , Smith Darrell R. , Fernyhough Paul 
Published: June 2021

Objective

Diabetic sensorimotor polyneuropathy (DSPN) affects about half of diabetic patients leading to significant morbidity in the form of ulcers, gangrene and lower limb amputation. Intractable pain is a major problem where therapy is imperfect. Recent studies have shown impaired growth factor signaling together with down‐regulation of AMP‐activated protein kinase (AMPK) and mitochondrial dysfunction in dorsal root ganglia (DRG) in animal models of type 1 and type 2 diabetes. We hypothesized that loss of IGF‐1 signaling in diabetes contributes to loss of AMPK activity and mitochondrial function in DRG neurons.

Methodology

Expression of genes linking IGF‐1 to mitochondrial function in intact DRGs isolated from streptozotocin (STZ)‐induced type 1 diabetic versus age matched control rats were analyzed using qRT‐PCR array. Adult DRG neurons were cultured under defined conditions from age‐matched control or STZ‐induced diabetic rats. Cultured adult neurons treated with/without IGF‐1 underwent qRT‐PCR and Western blotting for expression analysis of genes downstream from IGF‐1 signaling. In parallel, in IGF‐1 treated vs. control neuron cultures we determined (i) mitochondrial DNA (mtDNA)/nuclear DNA (nDNA) ratio using qRT‐PCR, and (ii) mitochondrial respiration (oxygen consumption rate; OCR) assessed using the Seahorse XF24. Finally, specific inhibitors and siRNAs against IGF‐1‐activated signaling cascades were utilized to dissect the pathways modulated by IGF‐1 to regulate mitochondrial protein expression and organelle function.

Results

Dysregulation of genes including IGF‐1, AMPKα2, ATP5a1 (subunit of ATPase) and peroxisome proliferator–activated receptor γ coactivator‐1β was observed in intact DRG of diabetic vs. control rats at the mRNA level. Exogenous IGF‐1 up‐regulated mRNA levels of these genes in cultured DRGs derived from control or diabetic rats. Short‐term IGF‐1 treatment (10nM for 15 min‐6h) of cultures significantly (P<0.05) increased phosphorylation of Akt, P70S6K (a downstream target of Akt involved in protein synthesis), AMPK (on T172) and acetyl‐CoA carboxylase (ACC, an endogenous target of AMPK). Mitochondrial gene expression was also augmented. Blockade of AMPK by a pharmacological inhibitor, compound C, suppressed IGF‐1 dependent activation ACC and Akt in DRG cultures from control rats. Twenty‐four hour treatment of DRG cultures with IGF‐1 significantly (P<0.05) enhanced mtDNA/nDNA ratio and mitochondrial OCR. The positive effect of IGF‐1 on OCR was prevented by (i) compound C, (ii) U0126 (ERK inhibitor), or (iii) AMPKα1‐specific siRNA.

Conclusions

IGF‐1 elevated an array of parameters related to mitochondrial function by acting, in part, through AMPK activation. Optimization of mitochondrial phenotype by IGF‐1 could be an effective therapeutic option in DSPN where mitochondrial dysfunction contributes to pathogenesis.

Support or Funding Information

Funded by CIHR grant # MOP‐130282 (P.F.)

This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.